Peptides in Sport: What Athletes Need to Know About BPC-157

Peptides in Sport: What Athletes Need to Know

Working with athletes across all levels, from amateur to professional, I’ve been asked one question more than almost any other recently: “What’s the deal with peptides?”

As a chiropractor working in high-performance environments, these conversations come up daily. Athletes hear about peptides through teammates, social media, podcasts, and training circles, often framed as a shortcut to faster healing or improved recovery. With so much information, and just as much misinformation, circulating in sport, it’s become increasingly important to address this topic properly.

Peptides are short chains of amino acids that serve as the building blocks of proteins. In recent years, they have gained prominence in the world of sports for their potential role in enhancing athletic performance and facilitating recovery. Athletes often turn to peptides due to their favorable safety profile when compared to more traditional performance-enhancing drugs. They are administered either via injection or, in some cases, orally, depending on the specific type of peptide and its intended use.

When athletes talk about peptides, they are usually referring to injectable compounds such as BPC-157, TB-500 (thymosin-β4–related peptides), CJC-1295, ipamorelin, and IGF-1–related substances. These compounds are frequently discussed in the context of tissue healing, inflammation reduction, and recovery support. At the same time, injectable peptides exist in a gray area between emerging science, regulation, and real risk. Understanding what these substances are, and just as importantly, what they are not, is essential for athletes who care about long-term health, performance, and eligibility.

This article provides an evidence-based overview of injectable peptides in sport, with a specific focus on BPC-157, the compound most commonly raised in current athletic and clinical conversations.

Understanding BPC-157: What It Is and How It Works

BPC-157, a synthetic peptide, is derived from a protein found in the stomach. Its full name is Body Protective Compound-157 and it notably possesses regenerative properties that appeal to athletes. Unlike nutritional peptides such as collagen, most injectable peptides promoted in sport lack robust human clinical research, particularly in athletic populations. Many are sold outside of regulated pharmaceutical channels, which raises concerns around safety, consistency, and legality in sport.

But what does the research say?

A 2024 systematic review published in the HSS Journal examined all available research on BPC-157 from an orthopaedic sports medicine perspective. That review identified 36 total studies published between 1993 and 2024. Importantly, 35 of those studies were preclinical, meaning they were conducted in animals or laboratory models. Only one small human study was identified, and it was retrospective in nature.

In animal and lab models, BPC-157 has been shown to reduce inflammatory markers, increase angiogenesis (new blood vessel formation), and improve structural and biomechanical healing in muscle, tendon, ligament, and bone injury models. These findings suggest biological plausibility, but they do not confirm predictable, safe outcomes in humans.

What’s missing is just as important as what exists. There are currently no randomized controlled trials in athletic populations, no FDA- or Health Canada-approved indications, no standardized dosing guidelines, and no high-quality human safety data. While preclinical and anecdotal reports have driven growing real-world use, BPC-157 remains experimental and investigational from a clinical and regulatory standpoint.

The Legal Status of BPC-157 in Sports

The legal status of BPC-157 is of considerable interest to athletes and sports organizations. The World Anti-Doping Agency (WADA), which oversees the anti-doping regulations in various sports, plays a crucial role in determining whether substances are permissible for athletes. As of now, It is specifically banned by the World Anti-Doping Agency (WADA) under the S0 “Non-Approved Substances” category, meaning it is prohibited both in and out of competition for tested athletes worldwide.

This prohibition is enforced across Olympic and international sport and is adopted directly or indirectly by many professional and collegiate leagues. While some leagues do not publicly list BPC-157 by name, organizations such as the National Collegiate Athletic Association (NCAA) and the National Football League (NFL) ban entire classes of peptide hormones and non-approved substances, which includes BPC-157.

According to guidance from the United States Anti-Doping Agency (USADA), athletes can be sanctioned for using BPC-157 regardless of how it is obtained, even if it is sold legally online or administered in a private clinic.

The use of BPC-157 remains a grey area and is subject to scrutiny. Major sports organizations may have their own policies that could classify this peptide differently. Athletes are therefore encouraged to consult the specific regulations of their respective sports organizations before considering the use of BPC-157 in their training regimens. The implications of using substances such as BPC-157 can be profound, particularly if they fall into questionable status upon the evaluation of an athlete's sample after competition.

Key takeaway:
Possession may be legal, but use can still result in a failed drug test and loss of eligibility.

Potential Benefits of BPC-157 for Athletes

Athletes are often drawn to peptides because of claims around faster healing, reduced inflammation, quicker return-to-play timelines, and improved training tolerance. While early preclinical research suggests some biologically plausible mechanisms, animal data does not equal clinical proof, especially in high-performance athletes under heavy training loads.

For athletes, the real question isn’t whether a compound sounds promising, it’s whether there is enough human evidence to justify the risk. At this point, for most injectable peptides, the answer is no.

The risks aren't always told clearly

One of the biggest real-world concerns is product quality. In Canada, Health Canada has issued multiple public advisories warning that unauthorized injectable peptide products are being sold online and through clinics without approval. These products have not been assessed for safety, efficacy, or quality and may pose serious health risks.

Beyond contamination and sterility risks, there is also the issue of unknown long-term effects. Even if an athlete experiences short-term symptom relief, there is no evidence establishing long-term safety, appropriate dosing, or interaction with high training volumes.

Practical Takeaways For Athletes

If you compete in a tested environment, injectable peptides should be considered high-risk for eligibility unless explicitly cleared through your sport’s medical and anti-doping channels. If a product is unregulated or coming from a questionable supply chain, you’re not just “trying recovery”, you’re accepting unknown purity, sterility, and health risks. From an evidence standpoint, the gap between hype and human data remains significant.

While BPC-157, a peptide that has gained attention within the athletic community, is often highlighted for its purported benefits in enhancing recovery and healing, it is essential to consider the potential risks and side effects associated with its use. Despite anecdotal evidence supporting its effectiveness, scientific research on the long-term impacts of BPC-157 is still limited.

Disclaimer

This article is for educational purposes only and does not constitute medical advice. It does not recommend or endorse the use of injectable peptides. Athletes should consult a licensed healthcare professional and review applicable sport regulations before making decisions related to supplementation or treatment.Unlike nutritional peptides such as collagen, most injectable peptides promoted in sport lack robust human clinical research, particularly in athletic populations. Many are sold outside of regulated pharmaceutical channels, which raises concerns around safety, consistency, and legality in sport.